Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Think globally, invest locally: Are KC dollars worth more than outside capital?
Hometown capital is validating, said Darcy Howe, but it isn’t everything. Half of the firms in Startland’s 2018 list of Top Venture Capital-Backed Companies in Kansas City received 50 percent or more of their funding from KC investors — a promising indicator of local support that suggests to outside investors that a company is ready…
2018 Top VC-Backed Companies in Kansas City List
The Top Venture Capital-Backed Companies in Kansas City List recognizes the growing cohort of growth-stage, venture-backed companies in the Kansas City metro — further illustrating the impact of the countless efforts aimed at boosting entrepreneurship in the region and creating a productive dialogue. The list is expected to be updated and published annually. The 2018…
Made in KC cocktails: Plaza tasting room infuses local spirits into 6 unique concoctions
No rum behind the bar? Ozzie Mendoza Diaz has the recipe for six Made in KC cocktails that feature only spirits from Kansas City-area distillers. And while the metro freely pours gin, vodka and even tequila for the thirsty masses, rum isn’t on the locally made menu — a problem for daiquiri lovers, said Tyler…
Entrepreneur’s pitch: Throw a life vest to those caring for loved ones with special needs
Families of loved ones with disabilities are fighting the clock, said Samantha Lane, Kansas City-area entrepreneur and founder of Lumina Advocacy and Coaching in Gardner. “There is a huge gap to be filled,” Lane said as she described the array of physical, intellectual, and sensory needs affecting — what she referenced as one-fifth of the American…